Potassium CITRATE ER Tablet
Potassium CITRATE ER is a compounded formulation containing Potassium CITRATE ER, prepared by Mixlab for veterinary use. Available by prescription.
The uses and pharmacology described below reflect the FDA-approved labeling for this active ingredient; your veterinarian determines whether and how they apply to your animal's treatment plan.
Potassium citrate ER is an extended-release urinary alkalizing agent utilized for the sustained management of the urinary environment. It is a prescription medication available for use in dogs and cats, frequently considered by veterinarians for patients presented with recurrent crystals where a consistent urinary pH is a clinical objective. The extended-release format is used in the context of managing the rate at which the medication is released into the body.
Prescription only. Use only under the direction of a licensed veterinarian. This information is not a substitute for veterinary diagnosis, prescribing or monitoring. Compounded drugs are not approved by the FDA for safety or effectiveness.
At a pharmacological level, it is used in the context of managing the concentration of citrate in the urine over an extended duration. It is important that ER tablets are swallowed whole; crushing or chewing them will may disrupt the extended-release profile. Commonly observed effects include localized digestive changes. Owners should monitor their pet for any unusual behavioral changes and contact their veterinarian promptly. Your veterinarian will provide guidance on the necessary duration and the specific monitoring schedule required for your pet's urinary health.
Yes. Potassium citrate ER is a prescription medication and requires a valid authorization from a licensed veterinarian. Mixlab ensures all professional standards are met before dispensing.
Crushing ER tablets will destroy the specialized coating that manages the release of the medication. This offers an approach to ensuring your pet receives the medication slowly as intended.
Veterinarians discuss the ER version because it provides more consistent management of the urinary pH over time. This offers an approach to managing the risk of crystal formation throughout the day.
You should monitor for observational signs like comfortable urination and a return of normal energy. Your veterinarian will perform periodic urinalysis to monitor the physiological response to the medication.
Extended-release medications are is used with caution in pets with certain digestive or renal challenges. Your veterinarian will determine if this management approach is appropriate for your individual pet.
